Location: Bethesda, Maryland
Medical Physics: Diagnostic Imaging
Diagnostic Radiology (DX)
Government and National Lab
The Molecular Imaging Branch (MIB) at the Center for Cancer Research (CCR) of the National Cancer Institute (NCI) is looking for a highly motivated individual to join the MIB in a multi-organizational effort to develop paired radiation detectors that can accurately locate annihilation events in space using only differences in photon arrival times (time-of-flight). Applicants should have received a Ph.D. degree within the last 5 years in physics or engineering (electrical or biomedical) and are expected to be familiar with the full range of contemporary radiation detection methods and computer codes simulating these methods. This individual will be mentored by Dr. Stephen Adler (MIB).
Successful candidates are expected to have hands-on experience with
- radiation detectors (scintillator or semiconductor based)
- modern photosensors like SiPMs, MCP-PMTs
- contemporary high-speed electronics and data acquisition systems
- programming languages such as C/C++, Python, LabVIEW or Matlab
- experience with Monte Carlo physics simulations like GATE/Geant4; familiarity with artificial intelligence, neural networks or similar tools is highly desirable.
The MIB is engaged in both clinical and pre-clinical research. Instrumentation development is part of this program and is intended to speed idenfication and use of new cancer diagnostics and therapeutics and to increase the breadth of these applications. We are part of the intramural program at NIH and are located on the NIH campus in Bethesda, Marylan
The appointment will be for two years with an extension to a third year based on performance. Qualified candidates should send their CVs to Dr. Stephen Adler ([email protected]).
DHHS, NIH and NCI are Equal Opportunity Employers. The NIH is dedicated to building a diverse community in its training and employment programs.
About National Cancer Institute/Molecular Imaging Branch
The molecular imaging branch is an intramural program of the National Cancer Institute develop targeted imaging methods that accelerate the development of cancer therapies. The MIB is focused on the development and translation of in vivo molecular imaging agents for early detection, monitoring and therapy. Given the high risks and high costs of conducting research in this field, the MIB is well positioned to address the challenges that the field of molecular imaging faces. The branch also has a physics team dedicated to developing cutting edge imaging technologies mostly focused on pre-clinical applications.